Embryotoxic effects of doxorubicin and N-trifluoroacetyladriamycin-14-valerate (AD-32)

Publisher Website
Google Scholar
Abstract
Anthracyclines are mutagenic, carcinogenic, and also cardiotoxic. Concern has been shown over the use of anthracycline anticancer drugs during pregnancy as these may be teratogenic to the human fetus. We have performed a series of experiments using the chick embryo to investigate and compare the toxic and teratogenic effects of doxorubicin (DX) and its new analog N‐trifluoroacetyladriamycin‐4‐valerate (AD‐32). DX and AD‐32, dissolved in 1:1 emulphor/ethanol and diluted to 1:4 with water, were injected into the air sac of white leghorn chick eggs at dose levels of 1‐20 μg (DX) and 5–100 μg (AD‐32) per egg. Eggs received a single injection of the drugs on days 1 and 2 of incubation. Control eggs were injected with an equivalent volume of the drug vehicle (0.05 ml per egg). Both of the drugs caused embryonic death, stunted growth, and various gross morphological malformations. Surviving embryos were sacrificed when they reached 13 days of incubation. The LD50 values for days 1 and 2 were as follows: (DX, 2.5 μg/egg on day 1 and 0.9 μg/egg on day 2; AD‐32, 10.6 μg/egg on day 1 and 11.8 μg/egg on day 2). Stunting of growth, a common anomaly with both drugs, decreased sharply from day 1 to day 2. The studies demonstrate that both DX and AD‐32 are toxic and teratogenic during the period of early organogenesis in the chick embryos. However, the toxic and teratogenic potentials of DX and AD‐32 differ quantitatively. AD‐32 is a more potent teratogen than DX when injected on day 1.